Panel Discussion: Clinical Implication of Novel Immuno-Oncology Biomarkers

Time: 7:05 pm
day: Clinical Implications of Novel Immuno-Oncology Biomarkers


  • Addressing the different challenges and advantages of novel liquid diagnostic approaches
  • Discussing large opportunities in the Immuno-Oncology field when it comes to developing drugs with high efficacy in both early and late-stage cancer
  • Unravelling the necessary steps to take a diagnostic tool all the way through to companion diagnostic approval